Patents by Inventor Mark I. Kemp

Mark I. Kemp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FKBP inhibitors
    Publication number: 20040058905
    Abstract: Compounds of formula (I), their salts and solvates, wherein the substituents are as described herein, are FKBP inhibitors.
    Type: Application
    Filed: April 1, 2003
    Publication date: March 25, 2004
    Applicant: Pfizer Inc.
    Inventors: Martin J. Wythes, Michael J. Palmer, Mark I. Kemp, Malcolm C. MacKenny, Robert J. Maguire, James F. Blake
  • FKBP inhibitors
    Patent number: 6686357
    Abstract: Compounds of formula (I), their salts and solvates, wherein the substituents are as described herein, are FKBP inhibitors.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: February 3, 2004
    Assignee: Pfizer, Inc.
    Inventors: Martin J. Wythes, Michael J. Palmer, Mark I. Kemp, Malcolm C. MacKenny, Robert J. Maguire, James F. Blake, Jr.
  • FKBP inhibitors
    Patent number: 6509464
    Abstract: Compounds of formula (I), their salts and solvates, wherein the substituents are as described herein, are FKBP inhibitors.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: January 21, 2003
    Assignee: Pfizer Inc
    Inventors: Martin J. Wythes, Michael J. Palmer, Mark I. Kemp, Malcolm C. MacKenny, Robert J. Maguire, James F. Blake, Jr.
  • FKBP inhibitors
    Patent number: 6495549
    Abstract: Compounds of formula (I), their salts and solvates, wherein the substituents are as described herein, are FKBP inhibitors.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: December 17, 2002
    Assignee: Pfizer Inc
    Inventors: Martin J. Wythes, Michael J. Palmer, Mark I. Kemp, Malcolm C. MacKenny, Robert J. Maguire, James F. Blake, Jr.
  • FKBP inhibitors
    Patent number: 6166011
    Abstract: Compounds of formula (I), their salts and solvates, wherein the substituents are as described herein, are FKBP inhibitors.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: December 26, 2000
    Assignee: Pfizer Inc
    Inventors: Martin J. Wythes, Michael J. Palmer, Mark I. Kemp, Malcolm C. MacKenny, Robert J. Maguire, James F. Blake, Jr.